Quick Answer
Shellfish allergy is the most common food allergy in adults, affecting approximately 2.9% of Americans. It is caused by IgE antibodies to shellfish proteins, principally tropomyosin. Shellfish allergy is usually lifelong, can cause severe anaphylaxis, and requires strict avoidance and epinephrine auto-injector prescription.
Types of Shellfish and Cross-Reactivity
Shellfish is divided into two groups: crustaceans (shrimp, crab, lobster, crayfish) and mollusks (clams, oysters, scallops, mussels, squid, octopus). Tropomyosin — a muscle protein highly conserved across crustaceans — is the major pan-crustacean allergen. High cross-reactivity exists among crustaceans, meaning patients allergic to shrimp are frequently allergic to crab and lobster as well.
Cross-reactivity between crustaceans and mollusks is lower — some patients react to one group but not the other. However, clinicians often advise patients to avoid all shellfish unless individual tolerances have been confirmed by a supervised oral food challenge. Cross-reactivity between shellfish and other arthropods (insects, mites) through shared tropomyosin is documented — some patients with shellfish allergy report reactions to dust mite exposure.
Symptoms and Severity
Shellfish allergy symptoms range from mild oral itching and hives to severe anaphylaxis. Unlike some childhood food allergies that produce mild reactions initially, adult-onset shellfish allergy can cause severe systemic reactions even with a relatively small first-reaction dose. Shellfish is among the most common causes of food allergy fatality in the United States, alongside peanut and tree nuts.
Symptoms typically begin within 30 minutes of ingestion and may include oral tingling, urticaria, abdominal cramping, vomiting, nasal congestion, difficulty breathing, throat tightening, and in severe cases cardiovascular collapse. Reactions to inhaled shellfish allergen (from cooking steam) are documented particularly in restaurant workers and some highly sensitized patients.
Diagnosis and the Iodine Myth
Shellfish allergy is diagnosed by specific IgE blood testing or skin prick testing with shellfish extracts. Component testing to tropomyosin can help confirm the diagnosis. Supervised oral food challenge is the gold standard for confirming the allergy and for evaluating tolerance to untested shellfish species.
A persistent medical myth suggests that shellfish-allergic patients cannot receive iodine-containing radiocontrast media or skin antiseptics (povidone-iodine). This is incorrect — shellfish allergy is to proteins (tropomyosin), not to iodine, and iodine is not an allergen. Patients with shellfish allergy are not at elevated risk for radiocontrast reactions, and no special precautions are needed based on shellfish allergy alone.
Management: Avoidance and Emergency Preparedness
Shellfish avoidance requires careful label reading, restaurant communication, and awareness of high-risk cuisines (Asian, Mediterranean, Cajun). Shellfish proteins are heat-stable, so cooking does not eliminate allergenicity. All shellfish-allergic patients should carry two prescribed epinephrine auto-injectors and have a physician-prepared emergency action plan.
Unlike peanut, there is currently no FDA-approved OIT product for shellfish allergy. Strict avoidance remains the primary management strategy. Patients should inform healthcare providers, anesthesiologists, and emergency personnel of their shellfish allergy, though the iodine/contrast cross-reactivity myth should not drive unnecessary clinical restrictions.
Key Takeaways
- Shellfish allergy affects 2.9% of Americans — the most common adult food allergy.
- Tropomyosin is the major pan-crustacean allergen; cross-reactivity among crustaceans is high.
- Shellfish allergy does NOT mean iodine allergy — the iodine cross-reactivity myth is incorrect.
- Shellfish allergy is typically lifelong and can cause severe anaphylaxis.
- All patients require two epinephrine auto-injectors and a written emergency action plan.
Related Guide
Food Allergies Hub →